Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Add To Watchlist

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Insiders

View:

Post by Stutters on Nov 17, 2022 8:36am

Insiders

on nov 15 +16 of november insiders bought over 73 000 shares. Interestingly enough, on Nov 15 the total volume was 22000 shares for the day, and on the 16 the volume was the total volume was 26100 shares. For a grand total of 48000 shares sold on nov 15 +16. These numbers dont correlate with the sedr report. Im assuming sedar is correct so any explanation to why the discrepency. ?

137